How Do Cancer Clinical Trial Phases Actually Work?

Clinical trials run in four phases. Phase I assesses safety and dosing, Phase II assesses whether a treatment shows a measurable effect, Phase III compares it against current standard care, and Phase IV continues monitoring after wider approval. Participation is voluntary at every stage and can be withdrawn at any time.

World Cancer Research Day falls on September 24, and at Burzynski Clinic in Houston, Texas, questions about trials come up regularly.

What Each Phase Is Designed to Answer

The phases are sequential because each one answers a question the next one depends on.

• Phase I asks whether a treatment is safe and at what dose, usually in a small group
• Phase II asks whether it produces a measurable effect in a specific condition
• Phase III compares it directly against current standard treatment in a larger population
• Phase IV continues collecting information after broader approval

A treatment in Phase I is at a much earlier stage of evidence than one in Phase III, which is worth understanding when weighing any specific trial.

Why Eligibility Is So Specific

Trials define eligibility criteria in detail, covering diagnosis, stage, prior treatment, organ function, and other health conditions.

This frustrates patients who want to enroll and cannot. The reasons are practical: narrow criteria produce interpretable results, and they exclude people for whom the treatment could pose particular risk.

Being ineligible is a statement about the trial's design, not about the patient.

What Informed Consent Actually Involves

Consent is a process rather than a form, and it is worth treating it that way.

You should receive a document describing the purpose, procedures, known risks, potential benefits, alternatives to participation, and your right to withdraw. You are entitled to take it home, read it slowly, and discuss it with family or another physician.

Signing does not commit you permanently. Withdrawal is possible at any point and should not affect the rest of your care.

Questions Worth Asking Before Enrolling

A good trial team will welcome these rather than deflect them.

What phase is this trial and what is it testing? What is the alternative if I do not enroll? What extra visits, tests, or travel will be required? Who covers the costs, including standard care costs? What happens if my condition changes during the trial? And will I be told the results?

That last question matters more than people expect, and the answer varies by trial.

Setting Expectations Honestly

A trial is neither a last resort nor a guarantee, and both framings cause problems.

It is a structured method for answering a question that has not been answered yet. Some trials demonstrate benefit, some do not, and that uncertainty is the entire reason the study exists.

Whether a trial fits your situation is a reasonable question to raise with your oncologist at any point, not only after other options have been exhausted.

"Research advances because patients agree to take part in questions that have not yet been settled. That deserves to be described accurately, including the uncertainty, rather than dressed up as something more certain than it is," says Stanislaw R. Burzynski, MD, PhD, Founder of Burzynski Clinic.

Frequently Asked Questions

Will I receive a placebo instead of treatment?

In cancer trials, placebo alone is uncommon. Comparison is usually against current standard treatment rather than nothing. Any trial should state clearly what the comparison arm involves, and you are entitled to ask before enrolling.

Can I leave a trial after starting?

Yes. Participation is voluntary and you may withdraw at any point without it affecting your other care. Telling the study team is important so any necessary follow up can be arranged safely.

How do I find out what trials exist for my diagnosis?

Your oncologist is the best starting point, since eligibility depends on details of your case. Public registries also list active studies, though interpreting eligibility criteria generally benefits from clinical input.

Ask Where Research Fits in Your Case

It is a fair question at any stage of care. To explore care at Burzynski Clinic in Houston, Texas, start the prospective patient process or call 1-713-335-5697.